Artemis Global Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 13.24 Cr
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2018
- Revenue Growth %
- Profit Growth -301.82%
- Ebitda -133.71%
- Net Worth -0.19%
- Total Assets -0.27%
About Artemis Global Life Sciences
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
L85191DL2011PLC216530
- Company No.
216530
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2011
- Date of AGM
14 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Listed
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Artemis Global Life Sciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devlina Chakravarty  | Managing Director | 04-Aug-2017 | Current |
| Anuj Sood | Company Secretary | 01-Apr-2017 | Current |
| Aastha Kalra | CFO | 01-Apr-2017 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ugar Anand | Director | 04-Aug-2017 | Current |
| Sanjaya Baru | Director | 30-Mar-2017 | Current |
| Akshaykumar Chudasama | Director | 30-Mar-2017 | Current |
| Harish Bahadur | Director | 25-Mar-2011 | Current |
| Onkar Kanwar | Director | 25-Mar-2011 | Current |
| Neeraj Kanwar | Director | 30-Mar-2017 | Current |
Financial Performance of Artemis Global Life Sciences.
Artemis Global Life Sciences Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 301.82% decrease in profit. The company's net worth dipped by a decrease of 0.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Artemis Global Life Sciences?
In 2018, Artemis Global Life Sciences had a promoter holding of 69.82% and a public holding of 30.18%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
360 One Wam LimitedSubbaraman Narayan is a mutual person
360 One Distribution Services LimitedSubbaraman Narayan is a mutual person
Artemis Medicare Services LimitedAkshaykumar Chudasama, Onkar Kanwar and 2 more are mutual person
Ptl Enterprises LimitedHarish Bahadur, Onkar Kanwar and 1 more are mutual person
Classic Industries And Exports LimitedHarish Bahadur, Onkar Kanwar and 1 more are mutual person
Artemis Cardiac Care Private LimitedDevlina Chakravarty is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Artemis Global Life Sciences?
Unlock and access historical data on people associated with Artemis Global Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Artemis Global Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Artemis Global Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
